Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!
Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...
Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.
Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.
3M to Acquire Wound Care Technology Co., Acelity for $6.7 Billion.
Chronic wounds represent a large and growing threat to public health. In the US alone, they affect over 6.5 million people. As...
Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.
‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg).
(Bloomberg) -- Shares of the tiny biotechnology company...
Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.
IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.
Mustang Bio (MBIO)$4.12, Reports 2018 Results.
Mustang Bio Reports Full-Year 2018 Financial Results And Recent Corporate Highlights
GlobeNewswire - Mon Mar 18, 6:29AM CDT
Must Watch Video: Dyadic’s (DYAI) Matthew Jones.
Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho...
Latest article
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such...
